Cerebral cavernous angiomas are known to be found in 0.4-0.5% of the population 1,2 and the incidence has increased with the advent of MRI. In one prospective study, 3 the gross detection rate (per 100 000 adults per year) for cavernous angioma was 0.56 compared with 2.27 for all intracranial vascular malformations. It has been reported that 34-70% of patients harboring supratentorial cavernous angioma have a history of seizures, 2 and a risk rate of new-onset seizures at an estimated rate of 2.4%/patientyear cumulatively over time.
Introduction
Cerebral cavernous angiomas are known to be found in 0.4-0.5% of the population 1,2 and the incidence has increased with the advent of MRI. In one prospective study, 3 the gross detection rate (per 100 000 adults per year) for cavernous angioma was 0.56 compared with 2.27 for all intracranial vascular malformations. It has been reported that 34-70% of patients harboring supratentorial cavernous angioma have a history of seizures, 2 and a risk rate of new-onset seizures at an estimated rate of 2.4%/patientyear cumulatively over time. 4 As many as 60% of patients who have symptomatic seizures may benefit from expectant management with antiepileptic drugs. [5] [6] [7] Nevertheless, surgical treatments tend to be favored because many of previous studies [8] [9] [10] [11] [12] [13] about surgical resection reported relatively good seizure outcomes and emphasized the importance of early surgery. But these studies had some limitations from an epileptic point of view. The first problem was that the eligible patients included the subset of patients whose chief complaint and major concern were not seizures, so that a selection bias could occur. The second problem was that most studies mainly dealt with the outcome of lesionectomy alone and a controlled seizure group, so the reports of the outcome regarding epilepsy surgery and a medically intractable group were scarce and the size of the population was very small. The third problem was that the definitions of medical intractability and outcome classification were different in each study, so a misclassification bias could occur and the comparison between the studies was not easy.
We present 60 consecutive patients with seizures who were divided into the intractable epilepsy group and the sporadic seizure group at first and then managed differently in accordance with our pre-established guidelines. The surgical outcomes, which are based on Engel classification, comparing the two groups and the surgical methods will be presented. Then, other factors affecting seizure outcomes will be discussed.
The aim of this study is to determine surgical outcomes and factors affecting seizure outcomes in patients who harbor supratentorial cavernous angiomas presenting with seizures.
Sixty patients were classified into the intractable epilepsy group (n = 22) and the sporadic seizure group (n = 38) and then managed differently in accordance with our guidelines. Patients exhibiting sporadic seizures were treated by lesionectomy, except for patients harboring mesial temporal lesions. We performed lesionectomy, extended lesionectomy, standard temporal lobectomy and tailored resection on 33, 9, 9 and 9 patients, respectively.
Finally, 72.7% (16/22) of patients with intractable epilepsy and 89.5% (34/38) of patients with sporadic seizures achieved Engel Class I outcomes. A long duration of illness was somewhat related to a poor outcome in patients with intractable epilepsy, yet this was not true of patients with sporadic seizures. Other factors which included age at onset, size of the lesions and locations were not related to seizure outcomes. The role of residual hemosiderin is yet to be discovered.
A lesionectomy alone can be considered a reasonable approach for those patients who exhibit sporadic seizures and have an extra-temporal or neo-temporal lesion. In patients with intractable epilepsy and/or mesial temporal lesions, a more invasive approach could achieve the better seizure outcome.
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Methods

Patient population
Between 1995 and 2005, 162 patients were admitted and operated on with a suspicion of harboring cavernous angiomas in our institute. Among 162 patients, those who had an infratentorial lesion and whose chief complaint and major concern were not seizure attacks were excluded, leaving 70 patients. None of them had a history of a symptomatic intracerebral hemorrhage. After the operations, four patients were excluded because pathological examinations revealed two patients with arteriovenous malformation, one patient with meningoangiomatosis and one patient with cysticercosis. After that, six patients were also excluded because of a short follow-up period; less than 12 months. Ultimately, 60 patients fell into this study population.
We classified our patients into the intractable epilepsy group and the sporadic seizure group. The term 'medical intractability' has been defined differently from study to study. Although the definition of intractability is still being debated, it is generally believed that seizures are intractable if they persist, despite appropriate medical management under the guidance of an experienced neurologist over a 2-year period. Practically, we think that this is not true of vascular malformations as cavernous angiomas, because the risks such as overt hemorrhages or neurologic deterioration due to mass effect always exist. Thus, we defined medically intractable epilepsy as seizure attacks that occurred continuously more than once per month despite at least two antiepileptic drugs with therapeutic range in a total illness duration of more than 1 year. There were 22 patients who fulfilled these criteria. The remaining 38 patients who did not fulfill these criteria were all classified into the sporadic seizure group.
Preoperative examinations
Clinical data from the history of patients were collected retrospectively. Age at initial seizure attack, sex, duration of illness, antiepileptic drug regimen and responsiveness to antiepileptic drugs were examined based on medical records. Preoperative MRIs were obtained for all patients. The location, size and number of lesions were examined and any co-existing lesions were also examined.
The temporal lesions were classified according to collateral sulcus into strictly neocortical and mesial temporal lesions, which include borderline and anterior temporal lesions. Routine scalp EEGs were performed on 47 patients including all patients with intractable epilepsy and/or mesial temporal lesion. Ictal video/EEG monitorings were performed on 19 patients. All but three patients harboring mesial temporal lesions received functional imaging studies which included positron emission tomography, ictal single photon emission tomography and intracarotid amobarbital testing (Wada test). Pre-and post-operative neuropsychological testings were performed wherever possible.
In nine patients among the intractable epilepsy group, subdural electrode plates (PMT Co., MN, U.S.A.) were placed widely over the lesion of MRI, the ictal onset zone of scalp EEG and eloquent areas. Three patients had a mesial temporal lesion and depth electrodes were positioned together in one of them. After inserting the electrodes, we analyzed the interictal and ictal epileptiform discharges during the video/electrocorticography (ECoG) monitoring. The ictal onset zones and the highly irritative zones were localized, and electrical cortical stimulations were performed to determine the border with eloquent areas. Intra-operative ECoGs were used in 34 patients and the pre-and post-resection electrographic spikes were compared. With the aid of intra-and extra-operative mapping procedures, the extent of resection was determined to be the areas in which the ictal onset zones, the highly irritative zones and cavernous angiomas were located. The electrophysiological monitorings and functional MRIs were also used if necessary.
Surgical procedures
We treated all patients (n = 56) according to our pre-established treatment strategy except four patients with multiple lesions. Multiple lesions were actually found in seven patients. However, three patients among them were not regarded as having multiple lesions because the lesions were adjacent to each other, so complete resection of all multiple lesions was possible. The remaining four patients who had un-operated lesions of other types were regarded as if they had multiple lesions and underwent a lesionectomy for the largest lesion only. Only one of them suffered from intractable epilepsy and had a history of receiving radiosurgery using a linear accelerator.
If the lesions were not multiple nor deeply located, our treatment strategies were as follows. Patients (n = 35) exhibiting sporadic seizures were treated by lesionectomy (n = 26), except for patients harboring mesial temporal lesions. These patients (n = 9) underwent standard temporal lobectomy (n = 4) or tailored resection (n = 2) according to the results of Wada test, regardless of medical intractability. There were three patients who were exceptionally treated by lesionectomy despite harboring the mesial temporal lesion. In fact, two of them underwent partial resection of the anterior temporal lobe including the lesion and were regarded as if they underwent lesionectomy, for the convenience of statistical analysis. All patients (n = 21) with intractable epilepsy were treated by different methods other than lesionectomy. Patients exhibiting intractable epilepsy with non-mesial temporal lesions were treated by extended lesionectomy (n = 9). Twelve patients harboring mesial temporal lesions were treated by standard temporal lobectomy (n = 5) or tailored resection (n = 7).
A lesionectomy refers to the complete removal of the cavernous angioma itself and may entail resection of surrounding hemosiderin-laden and gliotic tissue, but does not specifically or intentionally include the identification and resection of the surrounding epileptogenic cortex. 6 Our strategy was targeted to remove as much surrounding hemosiderin-laden and gliotic tissue as possible. Complete resection of the lesion itself with visual inspection was possible in all patients. Extended lesionectomy refers to lesionectomy plus corticectomy and involves the surgical removal of the cavernous angioma as well as the identification and resection of the surrounding epileptogenic cortex. Detailed techniques about standard temporal lobectomy including amygdalohippocampectomy and tailored resection are delineated elsewhere. All epilepsy surgeries including standard temporal lobectomies were performed by the same neurosurgeon.
Post-operative examinations
All patients continued to have follow-ups for more than 1 year. Thereafter, the further follow-up period was different for each patient according to the resolution of seizures. The outcome in relation to seizure control was based on the Engel classification, using all 13 subclasses. Every patient was asked to report the presence of aura or any kind of seizure attack at each follow-up visit with an interval of approximately 1-2 months. Data about the regimen and dosage of antiepileptic drugs were collected also. In 41 patients who continued to have follow-ups for more than 2 years, yearly changing Engel Classes were documented individually, and the last available Engel Class was used for statistical analysis. Completeness of resection and the presence of residual hemosiderin rim were verified after the operation on the basis of T2 weighted and gradient-echo MRI in the available 54 patients.
Statistical analysis
All data collected from each patient were organized in a database. Categorical data were compared between the two groups using Fisher's exact test. Continuous data were compared using Mann-Whitney rank test, because these data could not be taken to assume a normal distribution. Relationships between independent variables and outcomes were assessed using binary logistic regression for continuous data and cross-tabulation for categorical data, supposing that Engel Classes were re-grouped into Class I against Class II, III and IV (also, Class IA against Class IB-IV). All statistical tests were two tailed and p values of less than 0.05 were considered as significant after Bonferroni's correction. All statistical calculations were performed using commercially available software (SPSS version 13; SPSS Inc., Chicago, IL).
Results
Seizure outcomes in relation to medical intractability
Seizure outcomes of the intractable epilepsy group and the sporadic seizure group are compared in Table 1 and variables are listed in Table 2 . There were 10 patients whose Engel Class changed at the last follow-up visit. Six patients improved into Class IC from Class II and three patients improved into Class IIC from Class III. Only one patient worsened into Class III from Class II. Finally, 72.7% (16/ 22) of patients with intractable epilepsy and 89.5% (34/38) of patients with sporadic seizures can achieve Engel Class I outcome. Among these patients, 54.5% (12/22) of patients and 84.2% (32/38) of patients were completely seizure free since surgery (Engel Class IA), respectively.
There was no significant difference in sex, age at onset or length of follow up between these two groups. Seizure outcomes were also of no significance, although the sporadic seizure group tended to show somewhat more favorable outcomes. However, if Engel Classes were simply stratified into Engel Class IA against others (IB-IV), the intractable epilepsy group showed significantly poorer outcomes. The mean duration of illness, size of lesions, location and surgical method also differed from each other. In the intractable epilepsy group, the duration of illness was as long as expected, and the lesions tended to be small and located in the mesial temporal lobe.
Seizure outcomes in relation to the surgical methods Seizure outcomes in relation to surgical methods are summarized in Table 3 . There was no significant difference between lesionectomy and other methods. We performed a lesionectomy on 33 patients. Among them, 29 patients (87.9%) achieved an Engel Class I outcome and antiepileptic drugs could be tapered off in 25 patients. Three patients showed an Engel Class II outcome and one patient still suffers from continued seizures with no appreciable change (Class IVB). Further investigations will be conducted to the patient with a suspicion of concomitant cortical dysplasia. Complications occurred in six patients, which included hypesthesia, aphasia, upper extremity monoparesis and hemiparesis.
Extended lesionectomy was performed on nine patients. Six patients (66.7%) achieved an Engel Class I outcome and antiepileptic drugs can be successfully withdrawn from four of them. The outcome of remaining three patients was Engel Class II. In two of them, the Class II outcome might have resulted from insufficient resection of the epileptogenic cortex. The irritative zone confirmed by intra-operative ECoG could not be properly resected because we had not given informed consents about temporal lobe resection in one and we tried to preserve motor cortex in the other patient with an insular lesion. Complications developed in two patients, which were shoulder weakness and hemiplegia.
Standard temporal lobectomy including amygdalohippocampectomy or tailored resection was performed on 18 patients. Seizure outcomes appeared to be Engel Class I in 15 patients (83.3%) and 12 of these patients were eventually free of antiepileptic drugs. The outcomes of the other three patients corresponded to Engel Class IIC, Class IIIA and Class IVB each. All three patients suffered from intractable epilepsy, and two of them were preoperatively diagnosed as having bilateral temporal lobe epilepsy without laterality. The patient who showed an Engel Class IIIA outcome did not pass the Wada test, so the hippocampus was partially removed although intra-operative ECoG showed multiple spikes. After 54 months of follow-up, he still suffers from continued seizures and was the only man whose outcome deteriorated to a higher Engel Class compared with the outcome in the first post-operative year.
Further resection of his remaining hippocampus is under consideration. Complications include transient sensory aphasia in one patient and superior temporal quadrant-anopsia in another.
After the operation, a suitable amount of hippocampus for pathological examination was obtained from 14 patients. Dual pathology, which means the coexistence of hippocampal sclerosis with extra-hippocampal lesion, was found in two patients and their final outcomes were Engel Class IA and Class IIIA, respectively. Further, there were additional two patients who harbored microscopic changes involving conus ammonis layer 2 (Class IA) and dentate gyrus (Class IA).
Factors affecting seizure outcomes
The aforementioned variables were analyzed separately in each group to find out which one was related to seizure outcome irrespective of medical intractability or surgical methods. These variables included age at onset, duration of illness, size of the lesions and locations. The results are listed in Table 4 . Only duration of illness showed a statistical significance and this was meaningful in the non-lesionectomy group only when Engel Classes were simply bisected into Class IA against the other Classes.
The presence and amount of residual hemosiderin were of no significance in a whole population as shown in Table 5 . The location of residual hemosiderin in relation to cortex was also not related to seizure outcome. However, in the intractable epilepsy group and non-lesionectomy group, the residual hemosiderin was somewhat related to poor outcome (p = 0.033 and p = 0.091, respectively) only if Engel Classes were bisected into Engel Class IA against the others (Class IB-IV). When Engel Classes were bisected into Engel Class I and the others (Class II-IV), we could not find any significant relationship. In the sporadic seizure group and lesionectomy group, residual hemosiderin was also not predictive of poorer outcome.
Discussion
Surgical outcomes
A Medline search addressed to studies on cavernous angiomas, which included surgically treated cases of more than 30 and was published from 1995 to 2006, was performed. Differences in inclusion criteria, definitions of medical intractability, outcome classifications and presurgical diagnoses make a comparison of seizure outcome in the studies reviewed difficult. Even though these were not controlled studies, many authors reported that favorable seizure outcomes could be achieved by lesionectomy alone as shown in Table 6 .
Summing up the above studies, 8,9,11,13-16 a lesionectomy alone can be considered a reasonable approach with a chance for a seizure-free rate up to 70-90%, and this is especially true for those All p values are derived from binary logistic regression and Bonferroni's correction. The location is analyzed as a categorical variable. patients who have sporadic seizures and a history of less than 1 year. Therefore, a more invasive approach for patients with sporadic seizures should be reserved for persistent or relapsing cases. Our own finding that 87.5% (28/32) of patients with sporadic seizures who underwent a lesionectomy achieved an Engel Class I outcome also supports this. However, this result excluded a subset of patients harboring mesial temporal lesions. Our clinical data were collected retrospectively, so this could potentially introduce a selection bias and overestimate the outcomes. In the mean time, it is worthy to be considered that the lesion can be an incidental finding and may not play any role in seizure onset. As we experienced in one patient who showed an Engel Class IVB outcome, this may be the situation in up to 6% of cases in patients with epilepsy. 6 Some authors 16, 17 argued that a favorable outcome could be achieved after lesionectomy even in patients with intractable epilepsy. Kraemer et al. 17 reported 73.3% (11/15) of patients with intractable epilepsy had an Engel Class I outcome after lesionectomy. As shown in Table 6 , Casazza et al. 15 and Ferroli et al. 16 mentioned the seizure outcomes of patients with epilepsy lasting for more than 1 year (chronic epilepsy). However, their success rate of 61.9-65.7% after lesionectomy might be overstated due to lax criteria for medical intractability. According to the series by Baumann et al., 18 only 30.4% (7/23) of patients with intractable epilepsy who were treated by lesionectomy alone (amygdalohippocampectomy was added in patients with mesial temporal cavernous angioma) remained free from disabling seizures, 3 years after surgery. The fundamental question is whether the excision of epileptogenic zone results in a better seizure outcome than mere lesionectomy. This advantage has not been proved until now. There was no prospective or large-scaled study on this subject, and direct comparisons within or between studies were not possible because of obvious bias in selecting patients. Only a few results were available in the reviewed literature. Cohen et al. 9 reported 5 patients treated by extended lesionectomy together with 50 patients treated by lesionectomy alone. All five patients remained seizure-free following extended resection despite exhibiting intractable epilepsy. About mesial temporal lesions, some cases drawn from series regarding lesional temporal lobe epilepsy showed somewhat promising results after lobe resection. Stefan et al. 19 compared the seizure outcomes with respect to the surgical methods after treating 30 patients. They carried out lesionectomy, extended lesionectomy and modified lobe resection in 13, 11, and 6 patients, respectively. Overall, the seizure-free (Engel Class I) rate achieved after each procedure corresponded to 69.2% (9/13), 36.4% (4/11) and 50% (3/6), each. They concluded that the surgical method was not related to the seizure outcome.
Our own results also support their conclusion. However, this probably resulted from obvious selection bias and, in fact, this might be a counterevidence that a more invasive approach raised the seizure outcome in patients with intractable epilepsy. Although this study has some limitations as a retrospective uncontrolled study, our seizure-free rate of 71.4% (15/21) after epilepsy surgery or lobe resection was superior to that of above studies which dealt with the results after lesionectomy alone in patient with intractable epilepsy. So, it seems that the results following the more invasive approach may be somewhat superior to those of lesionectomy alone, because this approach is more likely to remove not only the regions of seizure onset but also the areas involved in seizure propagation and secondary epileptogenesis. 6, [20] [21] [22] Factors affecting seizure outcomes
The lesions located in the temporal area are worthy of concern. Although there are some reports 8, 9, 23 that seizure outcome after surgical resection was not related to the location, many of the articles 10, 15, 24, 25 commented that temporal cavernous angiomas had a worse prognosis and showed a tendency to be associated with intractable epilepsy. These differences probably resulted from differences in constituents harboring mesial temporal lesions involving the hippocampus. In patients with peri-limbic or anterior temporal lesion, dual pathology may co-exist either macroscopically or microscopically or only functional abnormalities within hippocampus may exist. 22, 26 Our result revealed that mesial temporal lesions were associated with intractable epilepsy and the location was not related to seizure outcomes as a single factor as shown in Tables 1  and 4 . But it does not mean that the mesial temporal lesion can be overlooked in patients with sporadic seizures, because the majority of our patients harboring mesial temporal lesions were not treated by lesionectomy alone irrespective of medical intractability. It is noteworthy that all six patients with sporadic seizures were completely seizure-free since resection of their temporal lobe (Engel Class IA). So, the mesial temporal location of lesions should be the important consideration when initial decisions for treatment are made even if they exhibit sporadic seizures and a quite favorable outcome can be anticipated with a more invasive approach. At the same time, the duration of seizures should also be considered together with frequency. This is a necessity for medical intractability, which is a key factor for approaching patients. Most studies [8] [9] [10] [11] [12] [13] about seizure outcome after surgery are in agreement that a long preoperative duration of illness is associated with a poor outcome. In other words, early operation, which reduces the preoperative duration of seizures, is associated with a better outcome. These findings are also supported by the series with arteriovenous malformations 25, 27 and with lesional mesial temporal lobe epilepsy. 28 However, our own findings show that these
results cannot be applied to all patients. The fact that a long duration of illness was not related to seizure outcome in patients with sporadic seizures may suggest that the results of previous studies were possibly obscured by medical intractability as a confounding variable.
In the mean time, in patients with intractable epilepsy, a long duration of illness was somewhat related to poor outcome only when Engel Classes were simply bisected into Class IA against the other Classes, although it was not statistically significant after Bonferroni's correction (p = 0.086). This discrepancy from different classification schemes could be explained by the so-called running down phenomenon. The hypothetical explanation of the running down phenomenon is thought to be the 'de-kindling'-an opposite process to secondary epileptogenesis, where the induced synaptic dysfunction gradually declines in the surrounding epileptogenic cortex after pace-maker resection. 29 There were four patients with intractable epilepsy whose Class was shifted to Class IC from Class II. Though their duration of illness was somewhat long when compared with those who had Class IA outcomes, it was relatively short when compared with those who showed worse outcomes. The fact that the duration of illness was significantly related to poor outcome in non-lesionectomy group (p = 0.006) implies that it was meaningful not only in patients with intractable epilepsy but also in those patients who exhibited sporadic seizures with mesial temporal lesions. Accordingly, patients with intractable epilepsy and/or mesial temporal lesions probably benefit from early operation, yet this may not be true of patients with sporadic seizures. Also, it can be cautiously assumed that sporadic seizures may result from the mass effect itself due to repeated microhemorrhages rather than hemosiderin-related cascades or secondary epileptogenesis. It is possible to say that the frequency can also be an important factor. Nevertheless, we could not investigate the frequency in this study, apart from medical intractability, because of limited data and difficulties in standardization and classification. Further investigation would be required on this subject. If the frequency has a more important impact on seizure outcome than the duration, the minimum requirement for intractability can be reduced to several months arbitrarily.
Another constant debate is the benefit after complete resection of the surrounding hemosiderin-laden and gliotic tissue. Considering the hemosiderin-related mechanism of epileptogenesis, 30, 31 it is generally agreed that the hemosiderin-stained or gliotic tissue should be removed in order to achieve complete relief of seizures. However, this was merely a hope and could not be proved in the clinical ground. Indeed, most studies 8, 13, 15, 16 suggested that this may be unnecessary, although Zevgaridis et al., 13 in some part, support the benefit of hemosiderin removal.
Recently, Baumann et al. 18 analyzed 31 patients with pharmacotherapy refractory epilepsy and reported that 58% (7/12) of patients, in whom hemosiderin had been removed completely, were classified into Engel Class I after 1 year, where as 63% (5/8), in whom hemosiderin was partially or not removed, were classified into Engel Class I after 1 year. Three years after operation, the Class I outcome deteriorated to 42% (5/12) and 14% (1/7), respectively. So they concluded that complete removal of hemosiderin-stained tissue may improve the long-term outcome. In our study, both the presence and the amount of residual hemosiderin were not predictive of seizure outcome in a whole population as other articles. The fact that it was meaningful only in patients with intractable epilepsy who had been completely seizure-free since surgery (Engel Class IA) is suggestive of a possible relationship with seizure outcome, but it is not true of patients with sporadic seizure. Aggressive resection of the hemosiderin-stained tissue during lesionectomy may be unnecessary to patients with sporadic seizures. At the same time, three of four patients with intractable epilepsy whose Class was shifted to Class IC from Class II had residual hemosiderin, thus it was also meaningless in patients who collectively achieved Engel Class I outcomes. Further, there are some evidences besides our own findings that patients with multiple lesions can well tolerate seizures even if other lesions remained untreated. Putting these together, we think that the residual hemosiderin can be just one necessity for continuation of seizures and is not a sufficient condition for continuation of seizures. It can be hypothesized that other unknown factors or processes including gliosis may play a more important role in epileptogenesis.
Conclusions
We managed patients with intractable epilepsy and/or mesial temporal lesion differently from patients with sporadic seizure in accordance with our pre-established guidelines. The results comparing the two groups and the surgical methods were presented. A lesionectomy alone can be considered a reasonable approach for those patients who exhibit sporadic seizures and have an extra-temporal or neo-temporal lesion. In patients with intractable epilepsy and/or mesial temporal lesions, a more invasive approach could achieve the better seizure outcome. Patients with intractable epilepsy and/or mesial temporal lesions probably benefit from early operation, yet this may not be true of patients with sporadic seizures. Other factors which included age at onset, size of the lesions and locations were not related to seizure outcomes. The role of residual hemosiderin is yet to be discovered. Further investigation would be required on the mechanisms of epilepsy and the impact of the preoperative seizure frequency.
